Figures
Following the publication of this article [1] concerns were raised regarding results presented in Figs 1, 2 and 5, and S1 Fig. Specifically,
- The SOX10 panel in Fig 1D appears similar to the SOX10 results in Figure 1E of [2], the SOX10 results in Figure 2C of [4], and the SOX10 results in Fig 1F of [5].
- The Nestin panel in Fig 1E appears similar to the Nestin results in Figure 1C of [2], and the Nestin results in Figure 2D of [3 retracted in 6].
- Within this article [1] the following panels appear more similar than would be expected from independent samples:
- Figure 2A Control Midbrain (14 days post-MPTP injection) and Fig 5A Control (PBS-PBS) NSpc (28 days post-MPTP injection).
- Figure 2A MPTP Striatum (14 days post-MPTP injection) and Fig 5B 70 days Striatum.
- Fig 5A MPTP-PBS SNpc and Fig 5C 28 days SNpc.
- S1B Fig MPTP Mice 14 days and S1B Fig Control Mice 70 days.
The authors explained that this study follows up from the results previously described in their Cellular and Molecular Life Sciences and PLOS ONE articles [2, 3 retracted in 6, 4], and preludes their PLOS ONE article [5], and clarify that the SOX10 panel in Fig 1D and the Nestin panel in Fig 1E represent the same experimental conditions as those panels presented in their other publications. As the original Figures presented in Fig 1D and 1E are not licensed for reproduction and distribution under the terms of the Creative Commons Attribution License (or Public Domain License for US gov), this article was republished on October 28, 2021 to remove this content and replace it with alternative relevant immunological characterization images. Please download this article again to view the correct version.
Furthermore, the authors explain that the wrong images were used to prepare the Fig 5A MPTP effect SNpc and MTPT + NCSC Stratum 70 days panels, the Fig 5C SNpc panel and the S1B Fig 70 days panel. The authors clarify that the wrong images were used inadvertently during figure preparation and explain that this error was introduced during the preparation of the figure; the correct samples were used for the quantification and the preparation of the associated graphs. The updated figures below were provided to relay the correct panels for Fig 5, but the authors explained that they were unable to provide a replacement panel for the S1B Fig 70 days result and S1 Fig has been updated to remove the incorrect panel. The originally published, uncorrected version of S1 Fig is provided in the S6 File below.
The updated Figs 1 and 5, and S1 Fig and their respective figure captions are provided here. The Board of Ethics and Scientific Integrity of the University of Liège investigated the overlap between the aforementioned panels and recommended the article be corrected. In addition, a member of PLOS ONE’s Editorial Board advised that the updated figures support the results and conclusions reported in the original article. However, the PLOS ONE Editors issue this Expression of Concern to due to the number of panels affected and the unavailability of the original MSCmix transplanted brains Control Mice 70 days results.
BMSC were harvested from double-transgenic Wnt1-CRE/R26R-LacZ mouse bone marrow (A). Amplification of the PGK-Neo cassette confirmed that NCSCmix underwent recombination, conversely to MSCmix (B). NCSCmix were β-galactosidase positive (blue, C), whereas MSCmix were not (blue, K) (Hematoxylin–stained nuclei). NCSCmix expressed neural crest-associated proteins Sox10 (green, D), Nestin (green, E) and p75NTR (green, F). MSCmix were Sox10-negative (green, L), weakly p75NTR-positive (green, N), and only a small proportion (<15%) of cells expressed nestin (green, M). MSCmix also expressed Sca-1 (green, O) and CD24 (green, P) while NCSCmix did not (green, G-H), and both types of cells were positive for Fzd-4 (green, I-Q). In NCSCmix, some β-tubulin-expressing cells were detected (in MesenCult medium) (green, J), but no cell in the MSCmix was β-tubulin-positive in those conditions (green, R) (DAPI-stained nuclei). (Scale bars = 30 μm).
A. Effect of MPTP on the integrity of dopaminergic nigro-striatal pathway (at 28 days post-MPTP treatment). B. NCSCmix graft in MPTP-treated mice. No increase in TH-positive (brown) striatal dopaminergic fibers and TH-positive cell bodies in the SNpc is observed, at 28 days as well as 70 days post- NCSCmix transplantation. C. The same observations were carried out after MSCmix transplantation. D. Number of TH-positive cell bodies in the SNpc of MPTP-treated mice that were transplanted with NCSCmix/MSCmix (p>0,05; Kruskall-Wallis ANOVA). Scale bars = 250 μm.
Supporting information
S1 Fig. Survival rate of grafted cells at 3, 7, 14, 28 and 70 days after transplantation of MSCmix/NCSCmix in MPTP and control mice.
A. In MPTP mice, the number of surviving NCSCmix in the right striatum (blue X-gal staining and purple Hematoxylin-stained nuclei) can reach 15% in the first week after transplantation, then the cells begin to disappear and after 4 weeks, we only observe a mean survival rate of 1%. In control mice, even if the number of surviving cells is higher at 3 and 7 days post-graft, the survival rate also decreases to 1% after 28 days. B. MSCmix (green CTG staining, blue DAPI-stained nuclei) seem to disappear more rapidly than NCSCmix, since no cells were observed starting from 14 days, in both MPTP and control mice. C. Number of grafted cells that were recovered in mice brains at different delays post transplantation (Mean ± SEM) (CC = Corpus callosum; LV = Lateral ventricle; Scale bars = 500 μm).
https://doi.org/10.1371/journal.pone.0256488.s001
(JPG)
S5 File. Originally published, uncorrected article with copyrighted images removed.
https://doi.org/10.1371/journal.pone.0256488.s006
(PDF)
S6 File. Originally published, uncorrected version of S1 Fig.
https://doi.org/10.1371/journal.pone.0256488.s007
(TIF)
References
- 1. Neirinckx V, Marquet A, Coste C, Rogister B, Wislet-Gendebien S (2013) Adult Bone Marrow Neural Crest Stem Cells and Mesenchymal Stem Cells Are Not Able to Replace Lost Neurons in Acute MPTP-Lesioned Mice. PLoS ONE 8(5): e64723. pmid:23741377
- 2. Wislet-Gendebien S, Poulet C, Neirinckx V, Hennuy B, Swingland JT, Laudet E, et al. (2012) In Vivo Tumorigenesis Was Observed after Injection of In Vitro Expanded Neural Crest Stem Cells Isolated from Adult Bone Marrow. PLoS ONE 7(10): e46425. pmid:23071568
- 3. Wislet-Gendebien S., Laudet E., Neirinckx V. et al. (2012) RETRACTED ARTICLE: Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences. Cell. Mol. Life Sci. 69, 2593–2608. pmid:22349262
- 4. Glejzer A., Laudet E., Leprince P. et al. (2011) Wnt1 and BMP2: two factors recruiting multipotent neural crest progenitors isolated from adult bone marrow. Cell. Mol. Life Sci. 68, 2101–2114. pmid:20976520
- 5. Coste C, Neirinckx V, Sharma A, Agirman G, Rogister B, Foguenne J, et al. (2017) Human bone marrow harbors cells with neural crest-associated characteristics like human adipose and dermis tissues. PLoS ONE 12(7): e0177962. pmid:28683107
- 6. Wislet-Gendebien S, Laudet E, Neirinckx V. et al. (2021) Retraction Note: Mesenchymal stem cells and neural crest stem cells from adult bone marrow: characterization of their surprising similarities and differences. Cell. Mol. Life Sci. 78, 5041. pmid:33963879
Citation: The PLOS ONE Editors (2021) Expression of Concern: Adult Bone Marrow Neural Crest Stem Cells and Mesenchymal Stem Cells Are Not Able to Replace Lost Neurons in Acute MPTP-Lesioned Mice. PLoS ONE 16(10): e0256488. https://doi.org/10.1371/journal.pone.0256488
Published: October 28, 2021
Copyright: © 2021 The PLOS ONE Editors. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.